Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)

NCT01996683 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Beta-thalassemia
Serum Ferritin
Iron Chelation Therapy

Interventions

DRUG: desferal, ferriprox, blood transfusion

Sponsor

Ain Shams University